Redhill Biopharma Ltd 's ability to collect accounts receivable sequentially worsen to 3.62, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Redhill Biopharma Ltd 's Accounts Receivable average collection period in the Dec 31 2025 quarter, has increased to 101 days, from 3 days, in the 0 quarter.

If we take a look into Healthcare sector 502 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from to 3503.

What is Receivable Turnover Ratio?
What is Redhill Biopharma Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RDHL Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-96.44 %	-	-	-	23.17 %
Receivable Turnover Ratio (TTM)	3.62	135.75	203.62	407.24	-
RDHL's Total Ranking	# 3503	#	#	#	# 3959
Accounts Receivable average collection period days	101	3	2	1	-
Seq. Receivable Change	0 %	0 %	0 %	-	-
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 162
Healthcare Sector	# 503
Overall Market	# 3503

Receivable Turnover Ratio Statistics
High	Average	Low
10.87	5.35	1.49
(Dec 31 2018)		(Dec 31 2023)

RDHL Company Profile • Back to RDHL Efficiency Comparisons • Compare RDHL Receivables Turnover Ratio to its Competitors

Financial Statements
Redhill Biopharma Ltd 's Accounts Receivable	$ 0 Millions	Visit RDHL's Balance sheet
Redhill Biopharma Ltd 's Sales TTM	$ 0 Millions	Visit RDHL's Income Statement
Sources of RDHL's Revenues		Visit RDHL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RDHL's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RDHL's Growth Rates	RDHL's Roa	RDHL's Inventory Turnover Ratio	RDHL's Dividend Comparisons
RDHL's Profitability Ratios	RDHL's Roi	RDHL's Asset Turnover Ratio	RDHL's Dividend Growth
RDHL's Valuation Ratios	RDHL's Roe	RDHL's Financial Strength Ratios	RDHL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Veracyte Inc	9.94	$ 489.532 Millions	$ 49.270 Millions
Zomedica Corp	9.93	$ 31.278 Millions	$ 3.150 Millions
Sanuwave Health Inc	9.92	$ 44.051 Millions	$ 4.439 Millions
Sunshine Biopharma Inc	9.91	$ 36.306 Millions	$ 3.662 Millions
Vireo Growth Inc.	9.89	$ 268.769 Millions	$ 27.182 Millions
Madrigal Pharmaceuticals Inc	9.87	$ 958.403 Millions	$ 97.105 Millions
International Stem Cell Corporation	9.86	$ 9.100 Millions	$ 0.923 Millions
Kestra Medical Technologies Ltd	9.85	$ 79.728 Millions	$ 8.092 Millions
Sol gel Technologies Ltd	9.85	$ 19.388 Millions	$ 1.968 Millions
Encompass Health Corporation	9.63	$ 5,935.200 Millions	$ 616.475 Millions
Biodesix Inc	9.62	$ 88.499 Millions	$ 9.200 Millions
Tandem Diabetes Care Inc	9.54	$ 1,011.039 Millions	$ 106.022 Millions
Prenetics Global Limited	9.51	$ 91.790 Millions	$ 9.656 Millions
Irhythm Holdings Inc	9.49	$ 746.250 Millions	$ 78.664 Millions
Septerna Inc	9.47	$ 45.951 Millions	$ 4.850 Millions
Pavmed Inc	9.47	$ 0.071 Millions	$ 0.008 Millions
Escalon Medical Corp	9.45	$ 12.311 Millions	$ 1.302 Millions
United Therapeutics Corporation	9.44	$ 3,182.700 Millions	$ 337.300 Millions
Immucell Corporation	9.38	$ 27.445 Millions	$ 2.925 Millions
Enanta Pharmaceuticals Inc	9.27	$ 66.980 Millions	$ 7.222 Millions
Radnet Inc	9.23	$ 2,040.210 Millions	$ 220.945 Millions
Lensar Inc	9.19	$ 58.435 Millions	$ 6.361 Millions
The Pennant Group Inc	9.17	$ 947.705 Millions	$ 103.348 Millions
Fresenius Medical Care Ag	9.17	$ 21,982.914 Millions	$ 2,397.664 Millions
Biocryst Pharmaceuticals Inc	9.14	$ 874.837 Millions	$ 95.679 Millions
Biofrontera Inc	9.13	$ 41.706 Millions	$ 4.568 Millions
Inogen Inc	9.03	$ 348.668 Millions	$ 38.613 Millions
Nuvation Bio Inc	9.00	$ 61.883 Millions	$ 6.875 Millions
The Oncology Institute Inc	8.94	$ 502.729 Millions	$ 56.225 Millions
Tactile Systems Technology Inc	8.78	$ 329.146 Millions	$ 37.478 Millions

Date modified: 2026-07-07T13:23:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.